Health In Tech, Inc. Class A Common Stock (HIT) is a publicly traded Technology sector company. As of November 17, 2026, HIT trades at $0.31 with a market cap of $25.83M and a P/E ratio of -11.50. HIT moved -7.22% today. Year to date, HIT is -82.00%; over the trailing twelve months it is -80.31%. Its 52-week range spans $0.30 to $4.02. Analyst consensus is buy with an average price target of $1.50. Rallies surfaces HIT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Health In Tech cuts 2026 revenue outlook to about $30 million: Health In Tech reported a $7.11 million Q3 net loss and lowered its 2026 revenue outlook to about $30 million, citing delayed policy starts during a carrier transition. Adjusted EBITDA was negative $3.93 million in Q3 and negative $6.6 million for the first nine months; distribution partners rose 16% year over year to 984.
| Metric | Value |
|---|---|
| Price | $0.31 |
| Market Cap | $25.83M |
| P/E Ratio | -11.50 |
| EPS | $-0.07 |
| Dividend Yield | 0.38% |
| 52-Week High | $4.02 |
| 52-Week Low | $0.30 |
| Volume | 520 |
| Avg Volume | 0 |
| Revenue (TTM) | $32.83M |
| Net Income | $-3.95M |
| Gross Margin | 53.93% |
2 analysts cover HIT: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $1.50.